Sign in
CRBP Stock Price, Chart, Stats & News
Corbus Pharmaceuticals Holdings, Inc.
Save
97.53M
Market cap
–
Current P/E
–
Forward P/E
CRBP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -46.69% |
ROE | -65.76% |
D/E | 0.01x |
Interest coverage ratio | – |
CRBP valuation
P/E | – |
P/S | – |
P/B | 0.79x |
P/CF | -1.80x |
P/FCF | -1.69x |
P/OCF | -1.80x |
PEG | 0.17x |
EV multiple | – |
About
Corbus Pharmaceuticals Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating immune modulators designed to combat immuno-oncology and various fibrotic conditions. Its pipeline includes lenabasum, an orally administered small molecule. This compound selectively activates cannabinoid receptor type 2 (CB2) and is currently undergoing Phase II clinical trials for the treatment of systemic lupus erythematosus.
Similar securities
Based on sector and market capitalization
Report issue